SCHEMBL7335115

SCHEMBL7335115

CCCC1C(=O)N(Cc2ccccc2)S(=O)(=O)N1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 3/20 0.53
KMT2A Q03164 5/20 0.46
KDM4E B2RXH2 2/20 0.40
PKM P14618 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
MEN1 O00255 4/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
EHMT2 Q96KQ7 1/20 0.38
ALDH1A1 P00352 4/20 0.37
GAA P10253 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MMP1 P03956 1/20 0.37
MMP3 P08254 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7339586 0.86 KMT2A (0.44) ELANEKMT2AKDM4EPKML3MBTL1
SCHEMBL7330348 0.79 ELANE (0.50) ELANEKMT2AKDM4ECA12CA9
SCHEMBL7419055 0.77 GFER (0.41) ELANEKDM4EPKML3MBTL1CYP1A2
SCHEMBL7329890 0.77 KDM4E (0.46) ELANEKMT2AKDM4EPKML3MBTL1
SCHEMBL7464643 0.73 GFER (0.41) ELANEKMT2AMEN1CYP1A2CYP2C9
SCHEMBL7332181 0.72 KMT2A (0.45) KMT2AKDM4EPKML3MBTL1CA12
SCHEMBL12169467 0.70 MEN1 (0.44) ELANEKMT2AKDM4EPKML3MBTL1
SCHEMBL7423743 0.70 GFER (0.38) ELANEKMT2AMEN1CYP1A2CYP2C9
SCHEMBL7329786 0.69 ELANE (0.54) ELANEKMT2APKMMEN1CYP1A2
SCHEMBL8316858 0.67 ELANE (0.39) ELANEKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750546-A SERINE PROTEASE INHIBITOR EFFECTIVE AGAINST DEGENERATIVE DISEASES, I.E., RESPIRATORY SYSTEM DISORDERS, RHEUMATOID ARTHRITIS SANOFI WINTHROP, INC. (US) 1998-05-12 US disclosed
EP-0793494-A4 2-HETEROCYCLYLOXY AND THIOMETHYL-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDES AND COMPOSITIONS AND METHOD OF USE THEREOF SANOFI WINTHROP INC (US) 1998-01-28 EP disclosed
EP-0793494-A1 2-HETEROCYCLYLOXY AND THIOMETHYL-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDES AND COMPOSITIONS AND METHOD OF USE THEREOF SANOFI WINTHROP, INC. (US) 1997-09-10 EP disclosed
US-5602154-A ADMINISTERING AN ENZYME INHIBITOR TREATING DEGENERATIVE DISEASES SANOFI WINTHROP, INC. (US) 1997-02-11 US disclosed
US-5556909-A PROTEOLYTIC ENZYME INHIBITOR, TREATMENT OF DEGENERATIVE DISEASES, SUCH AS EMPHYSEMA, RHEUMATOID ARTHRITIS AND PANCREATITIS SANOFI WINTHROP INC. (US) 1996-09-17 US disclosed
US-5541168-A PROTEOLYTIC ENZYME INHIBITORS; DEGENERATIVE DISEASES; RESPIRATORY, SKIN, GENETIC AND GASTROINTESTINAL DISORDERS; ANTIARRTHRITIC AND -INFLAMMATORY AGENTS; GENETIC DISEASES STERLING WINTHROP INC. (US) 1996-07-30 US disclosed
WO-1996016649-A1 2-HETEROCYCLYLOXY AND THIOMETHYL-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDES AND COMPOSITIONS AND METHOD OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-06-06 WO disclosed
WO-1996016970-A1 SUBSTITUTED 2-(PHOSPHINYLOXYMETHYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDES AND COMPOSITIONS AND METHOD OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-06-06 WO disclosed
US-5494925-A TREATING DEGENERATIVE DISORDERS; PROTEOLYTIC ENZYME INHIBITOR STERLING WINTHROP INC. (US) 1996-02-27 US disclosed